Frankfurt - Delayed Quote EUR

Baxter International Inc. (BTL.F)

27.39

-0.73

(-2.58%)

As of 8:59:02 AM GMT+2. Market Open.

3 Cash-Producing Stocks in the Doghouse

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

StockStory 2 days ago

BAX

SNAP
Baxter International First Quarter 2025 Earnings: Beats Expectations

Baxter International ( NYSE:BAX ) First Quarter 2025 Results Key Financial Results Revenue: US$2.63b (down 27% from 1Q...

Simply Wall St. 6 days ago

BAX
Baxter Declares Quarterly Dividend

DEERFIELD, Ill., May 06, 2025--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on July 1, 2025, to stockholders of record as of May 30, 2025. The indicated annual dividend rate is $0.68 per share of common stock.

Business Wire 7 days ago

BAX
Baxter International Inc (BAX) Q1 2025 Earnings Call Highlights: Strong Sales Growth and EPS ...

Baxter International Inc (BAX) reports a robust first quarter with a 5% sales increase and EPS exceeding guidance, despite macroeconomic challenges.

GuruFocus.com 12 days ago

BAX
Q1 2025 Baxter International Inc Earnings Call

Q1 2025 Baxter International Inc Earnings Call

Thomson Reuters StreetEvents 12 days ago

BAX
BAX Stock Gains Following Q1 Earnings Beat Estimates, Revenues Up Y/Y

Baxter reports better-than-expected first-quarter results. However, the company's gross margin contracts. Shares rise in pre-market.

Zacks 12 days ago

BAX
Baxter’s (NYSE:BAX) Q1: Beats On Revenue

Healthcare company Baxter International (NYSE:BAX) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 5.4% year on year to $2.63 billion. On the other hand, next quarter’s revenue guidance of $2.82 billion was less impressive, coming in 0.5% below analysts’ estimates. Its non-GAAP profit of $0.55 per share was 13.8% above analysts’ consensus estimates.

StockStory 12 days ago

BAX
Baxter (BAX) Reports Q1 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Baxter (BAX) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks 12 days ago

BAX
Baxter tops quarterly estimates on strong demand for medical devices

Boosted by a surge in non-essential surgical procedures, manufacturers such as Baxter expect the rise in the sale of medical devices to counter the impact of U.S. President Donald Trump's levies. "While today's global macroeconomic factors are creating a greater degree of uncertainty in the market, we remain confident in our overarching trajectory," interim CEO Brent Shafer said. First-quarter sales at Baxter's medical products and therapies unit, which includes IV solutions, rose 3% to $1.26 billion from a year ago.

Reuters 12 days ago

BAX
Baxter Reports First-Quarter 2025 Results

DEERFIELD, Ill., May 01, 2025--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the first quarter of 2025.

Business Wire 12 days ago

BAX
MedTech Stocks' Earnings to Watch on May 1: BDX, CAH, BAX, DXCM & SYK

The medical device industry is growing fast in 2025, but faces supply and trade issues. Major companies to report earnings on May 1, stay tuned!

Zacks 13 days ago

DXCM

CAH

SYK
Baxter (BAX) Reports Earnings Tomorrow: What To Expect

Healthcare company Baxter International (NYSE:BAX) will be announcing earnings results tomorrow before market hours. Here’s what to look for.

StockStory 14 days ago

BAX

BSX
Baxter to Present at Bank of America Securities 2025 Health Care Conference

DEERFIELD, Ill., April 29, 2025--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Bank of America Securities 2025 Health Care Conference on Tuesday, May 13, 2025. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 8:40 a.m. Pacific Time.

Business Wire 14 days ago

BAX
Will BAX's Q1 Earnings Improve Following Transformation Completion?

Baxter's first-quarter results are likely to reflect the favorable impact of kidney care sales. Growth in infusion therapies, pharmaceuticals and patient support systems to continue.

Zacks 15 days ago

BAX

A
Stocks to watch this week: Apple, Microsoft, Shell, HSBC, Lloyds and AstraZeneca

Earnings preview of key companies reporting next week and what to look out for.

Yahoo Finance UK 19 days ago

VSCFF

GBPEUR=X

GBP=X
Baxter to Host First-Quarter 2025 Financial Results Conference Call for Investors

DEERFIELD, Ill., April 15, 2025--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its first-quarter 2025 financial results on Thursday, May 1, 2025 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I763359 to pre-register for the call and receive the call information.

Business Wire 28 days ago

BAX
BAX Stock Declines Despite Latest Product Launch Boosting Patient Care

Baxter aims to promote enhanced patient care through the evolution of its latest product, which enables direct accessibility in the operating room.

Zacks 29 days ago

BAX

ABT
3 of Wall Street’s Favorite Stocks That Concern Us

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.

StockStory 29 days ago

ESTC

SPT

BAX
Baxter Launches New Room Temperature Hemopatch Sealing Hemostat for Rapid and Convenient Application During Surgery

VIENNA, April 10, 2025--Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the introduction of Hemopatch Sealing Hemostat with room temperature storage at a symposium in Austria. The evolution of the product optimizes accessibility in the operating room, delivering an immediate solution for surgeons to control bleeding or prevent leakage. The product is now available to order throughout Europe.

Business Wire last month

BAX
Baxter International (NYSE:BAX) CEO Change as Stock Dips 2% Last Quarter

Baxter International (NYSE:BAX) filed a proxy statement opposing a shareholder proposal to change executive stock retention policies; this move unfolded amidst recent leadership changes including the immediate retirement of CEO José Almeida and appointment of interim CEO Brent Shafer. The company reported a significant net loss for Q4 2024, alongside goodwill and asset impairments. Against market-wide turbulence, driven by the global trade tensions that saw major indexes, like the Dow and...

Simply Wall St. last month

BAX

Performance Overview

Return	BTL.F	S&P 500 (^GSPC)
YTD	+0.09%	+0.08%
1-Year	-13.55%	+12.20%
3-Year	-57.47%	+46.29%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Baxter International Inc. (BTL.F)

3 Cash-Producing Stocks in the Doghouse

Baxter International First Quarter 2025 Earnings: Beats Expectations

Baxter Declares Quarterly Dividend

Baxter International Inc (BAX) Q1 2025 Earnings Call Highlights: Strong Sales Growth and EPS ...

Q1 2025 Baxter International Inc Earnings Call

BAX Stock Gains Following Q1 Earnings Beat Estimates, Revenues Up Y/Y

Baxter’s (NYSE:BAX) Q1: Beats On Revenue

Baxter (BAX) Reports Q1 Earnings: What Key Metrics Have to Say

Baxter tops quarterly estimates on strong demand for medical devices

Baxter Reports First-Quarter 2025 Results

MedTech Stocks' Earnings to Watch on May 1: BDX, CAH, BAX, DXCM & SYK

Baxter (BAX) Reports Earnings Tomorrow: What To Expect

Baxter to Present at Bank of America Securities 2025 Health Care Conference

Will BAX's Q1 Earnings Improve Following Transformation Completion?

Stocks to watch this week: Apple, Microsoft, Shell, HSBC, Lloyds and AstraZeneca

Baxter to Host First-Quarter 2025 Financial Results Conference Call for Investors

BAX Stock Declines Despite Latest Product Launch Boosting Patient Care

3 of Wall Street’s Favorite Stocks That Concern Us

Baxter Launches New Room Temperature Hemopatch Sealing Hemostat for Rapid and Convenient Application During Surgery

Baxter International (NYSE:BAX) CEO Change as Stock Dips 2% Last Quarter

Performance Overview